ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Disturbed mitochondrial and peroxisomal dynamics due to loss of MFF causes Leigh-like encephalopathy, optic atrophy and peripheral neuropathy.
|
26783368 |
2016 |
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Genomic analysis of mitochondrial diseases in a consanguineous population reveals novel candidate disease genes.
|
22499341 |
2012 |
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genomic analysis of mitochondrial diseases in a consanguineous population reveals novel candidate disease genes.
|
22499341 |
2012 |
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Myocardial Infarction
|
0.300 |
Biomarker
|
disease |
CTD_human |
Knockdown of MFF attenuated hydrogen peroxide- and I/R injury-induced cardiomyocyte apoptosis and myocardial infarction.
|
23867156 |
2013 |
Ventricular Dysfunction, Left
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
miR-761 regulates the mitochondrial network by targeting mitochondrial fission factor.
|
23867156 |
2013 |
Colorectal Carcinoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Transient Ischemic Attack
|
0.200 |
Therapeutic
|
disease |
RGD |
Suppression of mitochondrial fission in experimental cerebral ischemia: The potential neuroprotective target of p38 MAPK inhibition.
|
26116440 |
2015 |
Optic Atrophy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Mitochondrial fusion is modulated by different proteins, including mitofusin-1 (MFN1), mitofusin-2 (MFN2) and optic atrophy (OPA-1), while fission is controlled by mitochondrial fission 1 (FIS1), dynamin-related protein 1 (DRP1) and mitochondrial fission factor (MFF).
|
28131082 |
2017 |
Seizures
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
We suggest that, even if laboratory findings are not indicative of mitochondrial or peroxisomal dysfunction, the co-occurrence of optic and/or peripheral neuropathy with seizures warrants genetic testing for MFF mutations.
|
26783368 |
2016 |
Peripheral Nervous System Diseases
|
0.110 |
Biomarker
|
group |
BEFREE |
Disturbed mitochondrial and peroxisomal dynamics due to loss of MFF causes Leigh-like encephalopathy, optic atrophy and peripheral neuropathy.
|
26783368 |
2016 |
Optic Atrophy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Seizures
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Peripheral Nervous System Diseases
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Astigmatism
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association studies for corneal and refractive astigmatism in UK Biobank demonstrate a shared role for myopia susceptibility loci.
|
30306274 |
2018 |
Tonometry
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analyses identify new loci influencing intraocular pressure.
|
29617998 |
2018 |
Deglutition Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Spasticity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperreflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
External Ophthalmoplegia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|